[1]
|
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71: 209-249. doi: 10.3322/caac.21660 |
[2]
|
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424. doi: 10.3322/caac.21492 |
[3]
|
Naga Ch P, Gurram L, Chopra S, et al. The management of locally advanced cervical cancer[J]. Curr Opin Oncol, 2018, 30: 323-329. doi: 10.1097/CCO.0000000000000471 |
[4]
|
Klopp AH, Yeung AR, Deshmukh S, et al. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203[J]. J Clin Oncol, 2018, 36: 2538-2544. doi: 10.1200/JCO.2017.77.4273 |
[5]
|
Chopra S, Gupta S, Kannan S, et al. Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial[J]. J Clin Oncol, 2021, 39: 3682-3692. doi: 10.1200/JCO.20.02530 |
[6]
|
Gandhi AK, Sharma DN, Rath GK, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study[J]. Int J Radiat Oncol Biol Phys, 2013, 87: 542-548. doi: 10.1016/j.ijrobp.2013.06.2059 |
[7]
|
Jadon R, Pembroke CA, Hanna CL, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer[J]. Clin Oncol (R Coll Radiol), 2014, 26: 185-196. doi: 10.1016/j.clon.2013.11.031 |
[8]
|
Barazzuol L, Coppes RP, van Luijk P. Prevention and treatment of radiotherapy-induced side effects[J]. Mol Oncol, 2020, 14: 1538-1554. doi: 10.1002/1878-0261.12750 |
[9]
|
Hale MF. Radiation enteritis: from diagnosis to management[J]. Curr Opin Gastroenterol, 2020, 36: 208-214. doi: 10.1097/MOG.0000000000000632 |
[10]
|
Åström LM, Behrens CP, Storm KS, et al. Online adaptive radiotherapy of anal cancer: Normal tissue sparing, target propagation methods, and first clinical experience[J]. Radiother Oncol, 2022, 176: 92-98. doi: 10.1016/j.radonc.2022.09.015 |
[11]
|
Christiansen RL, Dysager L, Hansen CR, et al. Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment[J]. Radiother Oncol, 2022, 167: 165-171. doi: 10.1016/j.radonc.2021.12.013 |
[12]
|
Kerkhof EM, Raaymakers BW, van der Heide UA, et al. Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study[J]. Radiother Oncol, 2008, 88: 241-249. doi: 10.1016/j.radonc.2008.04.009 |
[13]
|
Bertelsen AS, Schytte T, Møller PK, et al. First clinical experiences with a high field 1.5 T MR linac[J]. Acta Oncol, 2019, 58: 1352-1357. doi: 10.1080/0284186X.2019.1627417 |
[14]
|
Alongi F, Rigo M, Figlia V, et al. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment[J]. Radiat Oncol, 2020, 15: 69. doi: 10.1186/s13014-020-01510-w |
[15]
|
de Jong R, Visser J, van Wieringen N, et al. Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer[J]. Radiat Oncol, 2021, 16: 136. doi: 10.1186/s13014-021-01866-7 |